Showing all 2 results
Lamotrigine Tablets
FreeProduct Composition & Available Strengths
Because Lamotrigine demands highly delicate, low-dose introductory titration to ensure patient dermatological safety, we manufacture the full compendial strength matrix.
Active Ingredient Monograph Available Strengths Formulation Matrix Delivery System Primary Clinical Application Lamotrigine USP / BP / IP 25 mg Oral Solid Uncoated / Dispersible Tablet Dermatological Intro Titration: Mandatory low-dose baseline format utilized exclusively for the critical initial 2-week dose-escalation phase. Lamotrigine USP / BP / IP 50 mg Oral Solid Uncoated / Dispersible Tablet Intermediate Step-Up Dosing: Step-up strength calibrated for weeks 3 and 4 of therapy to safely approach steady-state plasma metrics. Lamotrigine USP / BP / IP 100 mg Oral Solid Compressed Tablet Standard Maintenance Block: First-line international standard strength for adult maintenance monotherapy in epilepsy and bipolar stabilization. Lamotrigine USP / BP / IP 200 mg Oral High-Potency Solid Tablet Maximal Saturation Maintenance: High-strength configuration calibrated for advanced refractory partial seizures and combination therapies. Phenobarbital Tablets
FreePhenobarbitone Tablets IP
Each Uncoated tablet contains :
Phenobarbitone IP 30 mg
Excipients q.sPhenobarbitone Tablets IP 60 mg
Phenobarbital Tablets IP 60 mg
Each Uncoated tablet contains :
Phenobarbitone IP 60 mg
Phenobarbital
Excipients q.sPhenobarbital Tablets BP
Each Uncoated tablet contains :
Phenobarbital BP 30 mgPhenobarbital Tablets BP 60 mg
Each Uncoated tablet contains :
Phenobarbital BP 60 mg Excipients q.sPHENOBARBITAL TABLETS BP 90 MG Each Uncoated tablet contains : Phenobarbital BP 90 mg
Excioients 0 QSPhenobarbital Tablets BP 100 mg
Each Uncoated tablet contains :
Phenobarbital BP 100 mg Excipients -QSUsage: – To control seizures
Category: – Anti Hypertensive / Cardiac Drugs
Therapeutic category: – Hypertensive
